Washington Trust Advisors, Inc. Bristol Myers Squibb CO Transaction History
Washington Trust Advisors, Inc.
- $1.06 Billion
- Q2 2024
A detailed history of Washington Trust Advisors, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Washington Trust Advisors, Inc. holds 7,282 shares of BMY stock, worth $391,480. This represents 0.03% of its overall portfolio holdings.
Number of Shares
7,282
Previous 7,274
0.11%
Holding current value
$391,480
Previous $394,000
23.35%
% of portfolio
0.03%
Previous 0.04%
Shares
11 transactions
Others Institutions Holding BMY
# of Institutions
2,403Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$10 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.53 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.92 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$4.01 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.18 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $114B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...